Aequs Limited will host a conference call for analysts and institutional investors on July 29, 2026, at 6:00 PM IST to discuss its unaudited financial results for the quarter ended June 30, 2026. The event provides stakeholders with direct access to management commentary on the company’s performance in Q1 FY27, followed by a question-and-answer session. This disclosure was made pursuant to Regulation 30 read with Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The conference call will feature key executives from Aequs Limited, including Aravind Melligeri, Executive Chairman and CEO; Rajeev Kaul, Cofounder and Managing Director; and Harish Bang, Vice President Finance. The management team will initiate the call with a brief discussion on business performance before opening the floor for investor queries. The intimation regarding the schedule was submitted to the National Stock Exchange of India Limited and BSE Limited on July 23, 2026.

Ernst & Young LLP, the statutory auditor, will also be represented during the proceedings to address any audit-related inquiries. Representatives from the firm include Diwakar Pingle, Kunal Bhoite, and Manav R Poal. Their presence ensures that investors can seek clarification on accounting treatments or financial reporting standards applied in the quarterly results.

Investors can access the conference call through multiple dial-in options, including universal and international toll-free numbers. A pre-registration link is available for participants who prefer to join via digital platforms. Detailed instructions and contact information for investor relations are provided below.

Conference Call Participation Details

The full intimation and invitation details are available on the company’s investor relations website at https://www.aequs.com/investor/ . For further assistance, investors may contact Harish Bang at Investor.relations@aequs.com or reach out to the Ernst & Young LLP team via their respective contact numbers.

Aequs Limited has commenced the remote e-voting process to seek shareholder approval for the amalgamation of three wholly-owned subsidiaries into the parent company. The resolution concerns the merger of AeroStructures Manufacturing India Private Limited, Aequs Engineered Plastics Private Limited, and Aequs Consumer Products Private Limited with Aequs Limited under Section 233 of the Companies Act, 2013. The primary objective of the merger is to simplify the group structure, achieve operational and financial efficiencies, optimize costs, and improve the competitive position of the combined entity.

The Board of Directors approved the scheme at meetings held on April 23, 2026, and May 26, 2026. The appointed date for the amalgamation is April 01, 2026. Since the transferor companies are wholly owned subsidiaries, no new shares will be issued, and there will be no change in the shareholding pattern of Aequs Limited. The statutory auditors of the transferor companies, M/s. B S R & Co. LLP, have issued reports on the statement of assets and liabilities as on March 31, 2026, confirming the solvency of the entities involved.

Key Dates for E-voting

The company has engaged KFin Technologies Limited to facilitate the remote e-voting process. The voting period is open to members whose names appear on the register of members or list of beneficial owners as on the cut-off date of June 26, 2026.

Financial and Operational Impact

The amalgamation is expected to result in greater integration, financial strength, and cost savings through synergies. The scheme does not involve any corporate debt restructuring. As the subsidiaries are wholly owned, the amalgamation will not have any financial impact on the consolidated level of the transferee company regarding leverage ratios, liquidity ratios, or top and bottom lines. The draft scheme has been filed with relevant regulatory authorities, including the Registrar of Companies, Income Tax Department, and Stock Exchanges, and no objections have been received within the prescribed period.